Do I think the re-marketing of a vaccine for Lyme Disease to the largely insured population here in the northeast could be a profit maker? Yes, I do.
Well, it's fine that you
think that, but the experiment has already been done and the results are in. GSK pulled the vaccine for lack of demand. If it were such a HUGE money maker, why would they possibly pull it off the market? Is the market so different now than it was in 2002? Are more people insured? Now, maybe you have information that the analysts on Wall Street and the market researchers within the pharmaceutical industry do not have, and that's how you know it would be profitable. Maybe all of these people who analyze market trends within the industry have it all wrong. If you're quite confident in your viewpoint, of course you could gather up all of your funds, maybe borrow a bit from your family, and possibly hit up some VC's (I'm sure they'd be all for it, it's an OBVIOUS winner) and license the vaccine from GSK and sell it yourself. Why not? You're sure to make a bundle. But you might ask yourself exacly why GSK has not done just that, considering that they own the patents, invented the technology, have appropriate facilities and really just need to press go.
Now, I don't really understand what your point was in including this:
Do I think the development of a vaccine for something I feel extremely beneficial to humankind, say HIV, would be available if the majority of those affected could pay for it? You betcha. And that just sucks. Case in point:
http://www.vaccineethics.org/issue_briefs/HIV_overview.php
: AIDS vaccine research is overwhelmingly driven by the public and philanthropic sectors. The HIV Vaccines and Microbicides Resource Tracking Working Group estimates that in 2006 the pharmaceutical industry spent approximately $79 million on AIDS vaccine research, only 8% percent of the total $933 million spent worldwide.8 Dr. Edward Tramont, Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases (NIAID), has suggested that drug companies lack incentives to create an HIV vaccine and are likely to wait to profit from a government-developed vaccine
It seems like you're just reinforcing my point, i.e. that inventing a vaccine is extremely difficult, and often not profitable. Am I missing something?
I stand by my statement: to suggest that vaccines are trivial to invent and HUGELY profitable is WILDLY fallacious (and also incorrect).
You further reinforce the point with:
To suffer the consequences without ever being infected would be very sad, indeed.
Correct. Perhaps without knowing it, you speak to one of the biggest challenges in developing vaccines: meeting the safety requirements. You're giving this compound to healthy people, many of whom are children. Think there's no risk here? Easy money? Think again.